Increased breath biomarkers of oxidative stress in diabetes mellitus

Clinica Chimica Acta

Volumn 344, Issue 1-2, 2004, Pages 189-194

  Phillips, Michael ^a,b   Cataneo, Renee N ^a   Cheema, Taseer ^c   Greenberg, Joel ^a  

^a MENSSANA RESEARCH INC   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NONE

Author keywords

Alkanes; Breath; Diabetes mellitus; Methylated alkanes; Oxidative stress

Indexed keywords

ALKANE; BIOLOGICAL MARKER; HEMOGLOBIN A1C; VOLATILE ORGANIC COMPOUND;

ADULT; AGE; ARTICLE; BREATH ANALYSIS; BREATHING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; GAS CHROMATOGRAPHY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METHYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; ALKANES; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MIDDLE AGED; ORGANIC CHEMICALS; OXIDATIVE STRESS; RISK FACTORS;

EID: 2442512205     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.02.025     Document Type: Article

References (25)

1. Rosen P., Nawroth P.P., King G., Moller W., Tritschler H.J., Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17:2001;189-212
2. Knight J.A. Free radicals: their history and current status in aging and disease. Ann. Clin. Lab. Sci. 28:1998;331-346
3. Bonnefont-Rousselot D., Bastard J.P., Jaudon M.C., Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab. 26:2000;163-176
4. West I.C. Radicals and oxidative stress in diabetes. Diabet. Med. 17:2000;171-180
5. Paredi P., Biernacki W., Invernizzi G., Kharitonov S.A., Barnes P.J. Exhaled carbon monoxide levels elevated in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? Chest. 116:1999;1007-1011
6. Wierusz-Wysocka B., Wysocki H., Byks H., Zozulinska D., Wykretowicz A., Kazmierczak M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res. Clin. Pract. 27:1995;193-197
7. Hartnett M.E., Stratton R.D., Browne R.W., Rosner B.A., Lanham R.J., Armstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care. 23:2000;234-240
8. Kneepkens C.M., Ferreira C., Lepage G., Roy C.C. The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. Clin. Invest. Med. 15:1992;163-186
9. Kneepkens C.M., Lepage G., Roy C.C. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic. Biol. Med. 17:1994;127-160
10. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal. Biochem. 247:1997;272-278
11. Phillips M., Herrera J., Krishnan S., Zain M., Greenberg J., Cataneo R.N. Variation in volatile organic compounds in the breath of normal humans. J. Chromatogr. B Biomed. Sci. Appl. 729:1999;75-88
12. Phillips M., Cataneo R.N., Greenberg J., Gunawardena R., Naidu A., Rahbari-Oskoui F. Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. J. Lab. Clin. Med. 136:2000;243-249
13. Phillips M., Cataneo R., Greenberg J., Gunawardena R., Rahbari-Oskoui F. Increased oxidative stress in younger as well as in older humans. Clin. Chim. Acta. 328:2003;83-86
14. Phillips M., Cataneo R., Greenberg J., Grodman R., Gunawardena R., Naidu A. Effects of oxygen on breath markers of oxidative stress. Eur. Respir. J. 21:2003;48-51
15. Moretti M, Phillips M, Abouzeid A, Cataneo R, Greenberg J. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia. Am J Obstet Gynecol (in press).
16. Desco M.C., Asensi M., Marquez R., et al. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes. 51:2002;1118-1124
17. Boemi M., Leviev I., Sirolla C., Pieri C., Marra M., James R.W. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis. 155:2001;229-235
18. Vessby J., Basu S., Mohsen R., Berne C., Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J. Intern. Med. 251:2002;69-76
19. Hammes H.P., Brownlee M., Lin J., Schleicher E., Bretzel R.G. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia. 42:1999;603-607
20. Ha H., Lee H.B. Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int. Suppl. 77:2000;S19-S25
21. Ceriello A., Morocutti A., Mercuri F., et al. Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes. 49:2000;2170-2177
22. Androne L., Gavan N.A., Veresiu I.A., Orasan R. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy. In Vivo. 14:2000;327-330
23. Chistyakov D.A., Savost'anov K.V., Zotova E.V., Nosikov V.V. Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med. Genet. 2:2001;4
24. Mackness B., Durrington P.N., Boulton A.J., Hine D., Mackness M.I. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. Eur. J. Clin. Invest. 32:2002;259-264
25. Skyrme-Jones R.A., O'Brien R.C., Luo M., Meredith I.T. Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes. J. Am. Coll. Cardiol. 35:2000;292-299